XML 30 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information
6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Segment Information
Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

Effective January 1, 2018, as required, the Company adopted ASU No. 2017-07, “Compensation–Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost” on a retrospective basis. To conform to the current year’s presentation, for the three and six months ended June 30, 2017, the Company reclassified $25 and $52, respectively, of non-service related components of pension and other postretirement costs, which was previously deducted from Operating profit, to a new line item, “Non-service related postretirement costs,” which is below Operating profit. The impact of the reclassification from Operating profit by segment for the three months ended June 30, 2017 is as follows: North America $14, Latin America $1, Europe $1, Asia Pacific $1, Africa/Eurasia $0, Pet Nutrition $6 and Corporate $2. The impact of the reclassification from Operating profit by segment for the six months ended June 30, 2017 is as follows: North America $28, Latin America $3, Europe $3, Asia Pacific $1, Africa/Eurasia $1, Pet Nutrition $12 and Corporate $4. The reclassification had no effect on Net income attributable to Colgate-Palmolive Company, Earnings per common share or Cash flow.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales by segment were as follows:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2018
 
2017
 
2018
 
2017
Net sales
 
 
 
 
 
 
 
Oral, Personal and Home Care
 
 
 
 
 
 
 
North America
$
824

 
$
764

 
$
1,651

 
$
1,524

Latin America
933

 
1,002

 
1,862

 
1,926

Europe
620

 
584

 
1,268

 
1,142

Asia Pacific
674

 
663

 
1,433

 
1,383

Africa/Eurasia
243

 
241

 
498

 
487

Total Oral, Personal and Home Care
3,294

 
3,254

 
6,712

 
6,462

Pet Nutrition
592

 
572

 
1,176

 
1,126

Total Net sales
$
3,886

 
$
3,826

 
$
7,888

 
$
7,588



Approximately 75% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).
The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2018
 
2017
 
2018
 
2017
Net sales
 
 
 
 
 
 
 
Oral Care
47
%
 
47
%
 
48
%
 
48
%
Personal Care
20
%
 
20
%
 
19
%
 
19
%
Home Care
18
%
 
18
%
 
18
%
 
18
%
Pet Nutrition
15
%
 
15
%
 
15
%
 
15
%
Total Net sales
100
%
 
100
%
 
100
%
 
100
%

Operating profit by segment was as follows:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2018
 
2017
 
2018
 
2017
Operating profit
 
 
 
 
 
 
 
Oral, Personal and Home Care
 
 
 
 
 
 
 
North America
$
264

 
$
255

 
$
521

 
$
502

Latin America
262

 
309

 
535

 
580

Europe
156

 
146

 
318

 
288

Asia Pacific
203

 
206

 
429

 
425

Africa/Eurasia
42

 
45

 
92

 
91

Total Oral, Personal and Home Care
927

 
961

 
1,895

 
1,886

Pet Nutrition
165

 
169

 
329

 
332

Corporate
(146
)
 
(252
)
 
(295
)
 
(428
)
Total Operating profit
$
946

 
$
878

 
$
1,929

 
$
1,790



For the three and six months ended June 30, 2018, Corporate Operating profit (loss) included charges of $58 and $82, respectively, resulting from the Global Growth and Efficiency Program.

For the three and six months ended June 30, 2017, Corporate Operating profit (loss) included charges of $141 and $186, respectively, resulting from the Global Growth and Efficiency Program.

For further information regarding the Global Growth and Efficiency Program, refer to Note 5, Restructuring and Related Implementation Charges.